Literature DB >> 9660629

Recent developments in computer-assisted analysis of mixtures.

D Böhning1, E Dietz, P Schlattmann.   

Abstract

This paper reviews recent developments in the area of computer-assisted analysis of mixture distributions (C.A.MAN). Given a biometric situation of interest in which, under homogeneity assumptions, a certain parametric density occurs, such as the Poisson, the binomial, the geometric, the normal, and so forth, then it is argued that this situation can easily be enlarged to allow a variation of the scalar parameter in the population. This situation is called unobserved heterogeneity. This naturally leads to a specific form of nonparametric mixture distribution that can then be assumed to be the standard model in the biometric application of interest (since it also incorporates the homogeneous situations as a special case). Besides developments in theory and algorithms, the work focuses on developments in biometric applications such as meta-analysis, fertility studies, estimation of prevalence under clustering, and estimation of the distribution function of survival time under interval censoring. The approach is nonparametric for the mixing distribution, including leaving the number of components (subpopulations) of the mixing distribution unknown.

Entities:  

Mesh:

Year:  1998        PMID: 9660629

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysis.

Authors:  Annabelle Lemenuel-Diot; Christian Laveille; Nicolas Frey; Roeline Jochemsen; Alain Mallet
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-12-07       Impact factor: 2.745

2.  Evolution of protein domain promiscuity in eukaryotes.

Authors:  Malay Kumar Basu; Liran Carmel; Igor B Rogozin; Eugene V Koonin
Journal:  Genome Res       Date:  2008-01-29       Impact factor: 9.043

3.  Meta-analysis of Diagnostic Accuracy and ROC Curves with Covariate Adjusted Semiparametric Mixtures.

Authors:  Philipp Doebler; Heinz Holling
Journal:  Psychometrika       Date:  2014-11-01       Impact factor: 2.500

4.  Modelling the progression towards duodenal cancer among patients with familial polyposis on the basis of two different score profiles.

Authors:  C Gutknecht; J Iwaz; F Boutitie; J C Saurin; R Ecochard
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Estimating the number of drug users in Bangkok 2001: a capture-recapture approach using repeated entries in one list.

Authors:  Dankmar Böhning; Busaba Suppawattanabodee; Wilai Kusolvisitkul; Chukiat Viwatwongkasem
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Authors:  An Tran-Duy; Annelies Boonen; Wietske Kievit; Piet L C M van Riel; Mart A F J van de Laar; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

7.  IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?

Authors:  Sabine Altrichter; Hans-Jürgen Peter; Dina Pisarevskaja; Martin Metz; Peter Martus; Marcus Maurer
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

8.  Negative correlation between expression level and evolutionary rate of long intergenic noncoding RNAs.

Authors:  David Managadze; Igor B Rogozin; Diana Chernikova; Svetlana A Shabalina; Eugene V Koonin
Journal:  Genome Biol Evol       Date:  2011-11-09       Impact factor: 3.416

9.  AID/APOBEC cytosine deaminase induces genome-wide kataegis.

Authors:  Artem G Lada; Alok Dhar; Robert J Boissy; Masayuki Hirano; Aleksandr A Rubel; Igor B Rogozin; Youri I Pavlov
Journal:  Biol Direct       Date:  2012-12-18       Impact factor: 4.540

10.  A measure of the concentration of rare events.

Authors:  Rafael Prieto Curiel; Steven Bishop
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.